Insulin-like growth factor 1 receptor expression and <em>IGF1R</em> 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 201
Bioportfolio,
Stefanie de Groot, Ayoub Charehbili, Hanneke van Laarhoven, Antien Mooyaart, N.